43 result(s) have been found!
| Accession | Name | Sequence | Source/Organism | Mechanism | Assay Type | Cell Line | Cancer Type | Activity |
|---|---|---|---|---|---|---|---|---|
| dbacp01959 | Brevinin-2R | KLKNFAKGVAQSLLNKASCKLSGQC | Skin, Marsh frog, Europe | Activates the lysosomal-mitochondrial death pathway; Involves autophagy-like cell death | MTT-assay | Jurkat | T-cell Leukemia | LD50 : 10 – 15 μg/ml |
| dbacp01960 | Brevinin-2R | KLKNFAKGVAQSLLNKASCKLSGQC | Skin, Marsh frog, Europe | Activates the lysosomal-mitochondrial death pathway; Involves autophagy-like cell death | MTT-assay | Jurkat | T-cell Leukemia | LD50 : 20 – 25 μg/ml |
| dbacp01961 | Brevinin-2R | KLKNFAKGVAQSLLNKASCKLSGQC | Skin, Marsh frog, Europe | Activates the lysosomal-mitochondrial death pathway; Involves autophagy-like cell death | MTT-assay | Jurkat | T-cell Leukemia | LD50 : 30 – 40 μg/ml |
| dbacp01962 | Brevinin-2R | KLKNFAKGVAQSLLNKASCKLSGQC | Skin, Marsh frog, Europe | Activates the lysosomal-mitochondrial death pathway; Involves autophagy-like cell death | MTT-assay | BJAB | B-cell lymphoma | LD50 : 10 – 15 μg/ml |
| dbacp01963 | Brevinin-2R | KLKNFAKGVAQSLLNKASCKLSGQC | Skin, Marsh frog, Europe | Activates the lysosomal-mitochondrial death pathway; Involves autophagy-like cell death | MTT-assay | BJAB | B-cell lymphoma | LD50 : 20 – 25 μg/ml |
| dbacp01964 | Brevinin-2R | KLKNFAKGVAQSLLNKASCKLSGQC | Skin, Marsh frog, Europe | Activates the lysosomal-mitochondrial death pathway; Involves autophagy-like cell death | MTT-assay | BJAB | B-cell lymphoma | LD50 : 30 – 40 μg/ml |
| dbacp01965 | Brevinin-2R | KLKNFAKGVAQSLLNKASCKLSGQC | Skin, Marsh frog, Europe | Activates the lysosomal-mitochondrial death pathway; Involves autophagy-like cell death | MTT-assay | HT29/219 | Colon carcinoma | LD50 : 10 – 15 μg/ml |
| dbacp01966 | Brevinin-2R | KLKNFAKGVAQSLLNKASCKLSGQC | Skin, Marsh frog, Europe | Activates the lysosomal-mitochondrial death pathway; Involves autophagy-like cell death | MTT-assay | HT29/219 | Colon carcinoma | LD50 : 20 – 25 μg/ml |
| dbacp01967 | Brevinin-2R | KLKNFAKGVAQSLLNKASCKLSGQC | Skin, Marsh frog, Europe | Activates the lysosomal-mitochondrial death pathway; Involves autophagy-like cell death | MTT-assay | HT29/219 | Colon carcinoma | LD50 : 30 – 40 μg/ml |
| dbacp01968 | Brevinin-2R | KLKNFAKGVAQSLLNKASCKLSGQC | Skin, Marsh frog, Europe | Activates the lysosomal-mitochondrial death pathway; Involves autophagy-like cell death | MTT-assay | SW742 | Colon carcinoma | LD50 : 10 – 15 μg/ml |
| dbacp01969 | Brevinin-2R | KLKNFAKGVAQSLLNKASCKLSGQC | Skin, Marsh frog, Europe | Activates the lysosomal-mitochondrial death pathway; Involves autophagy-like cell death | MTT-assay | SW742 | Colon carcinoma | LD50 : 20 – 25 μg/ml |
| dbacp01970 | Brevinin-2R | KLKNFAKGVAQSLLNKASCKLSGQC | Skin, Marsh frog, Europe | Activates the lysosomal-mitochondrial death pathway; Involves autophagy-like cell death | MTT-assay | SW742 | Colon carcinoma | LD50 : 30 – 40 μg/ml |
| dbacp01971 | Brevinin-2R | KLKNFAKGVAQSLLNKASCKLSGQC | Skin, Marsh frog, Europe | Activates the lysosomal-mitochondrial death pathway; Involves autophagy-like cell death | MTT-assay | L929 | Fibrosarcoma | LD50 : 10 – 15 μg/ml |
| dbacp01972 | Brevinin-2R | KLKNFAKGVAQSLLNKASCKLSGQC | Skin, Marsh frog, Europe | Activates the lysosomal-mitochondrial death pathway; Involves autophagy-like cell death | MTT-assay | L929 | Fibrosarcoma | LD50 : 20 – 25 μg/ml |
| dbacp01973 | Brevinin-2R | KLKNFAKGVAQSLLNKASCKLSGQC | Skin, Marsh frog, Europe | Activates the lysosomal-mitochondrial death pathway; Involves autophagy-like cell death | MTT-assay | L929 | Fibrosarcoma | LD50 : 30 – 40 μg/ml |
| dbacp01974 | Brevinin-2R | KLKNFAKGVAQSLLNKASCKLSGQC | Skin, Marsh frog, Europe | Activates the lysosomal-mitochondrial death pathway; Involves autophagy-like cell death | MTT-assay | MCF-7 | Breast adenocarcinoma | LD50 : 10 – 15μg/ml |
| dbacp01975 | Brevinin-2R | KLKNFAKGVAQSLLNKASCKLSGQC | Skin, Marsh frog, Europe | Activates the lysosomal-mitochondrial death pathway; Involves autophagy-like cell death | MTT-assay | MCF-7 | Breast adenocarcinoma | LD50 : 20 – 25 μg/ml |
| dbacp01976 | Brevinin-2R | KLKNFAKGVAQSLLNKASCKLSGQC | Skin, Marsh frog, Europe | Activates the lysosomal-mitochondrial death pathway; Involves autophagy-like cell death | MTT-assay | MCF-7 | Breast adenocarcinoma | LD50 : 30 – 40 μg/ml |
| dbacp01977 | Brevinin-2R | KLKNFAKGVAQSLLNKASCKLSGQC | Skin, Marsh frog, Europe | Activates the lysosomal-mitochondrial death pathway; Involves autophagy-like cell death | MTT-assay | A549 | Lung carcinoma | LD50 : 10 – 15 μg/ml |
| dbacp01978 | Brevinin-2R | KLKNFAKGVAQSLLNKASCKLSGQC | Skin, Marsh frog, Europe | Activates the lysosomal-mitochondrial death pathway; Involves autophagy-like cell death | MTT-assay | A549 | Lung carcinoma | LD50 : 20 – 25 μg/ml |
| dbacp01979 | Brevinin-2R | KLKNFAKGVAQSLLNKASCKLSGQC | Skin, Marsh frog, Europe | Activates the lysosomal-mitochondrial death pathway; Involves autophagy-like cell death | MTT-assay | A549 | Lung carcinoma | LD50 : 30 – 40 μg/ml |
| dbacp01980 | Brevinin-2R | KLKNFAKGVAQSLLNKASCKLSGQC | Skin, Marsh frog, Europe | Activates the lysosomal-mitochondrial death pathway; Involves autophagy-like cell death | MTT-assay | Jurkat | T-cell Leukemia | LD50 : 20 – 25 µg/mll |
| dbacp01981 | Brevinin-2R | KLKNFAKGVAQSLLNKASCKLSGQC | Skin, Marsh frog, Europe | Activates the lysosomal-mitochondrial death pathway; Involves autophagy-like cell death | MTT-assay | BJAB | B-cell lymphoma | LD50 : 30 – 40 µg/ml |
| dbacp01982 | Brevinin-2R | KLKNFAKGVAQSLLNKASCKLSGQC | Skin, Marsh frog, Europe | Activates the lysosomal-mitochondrial death pathway; Involves autophagy-like cell death | MTT-assay | L929 | Fibrosarcoma | LD50 : 20 – 25 µg/ml |
| dbacp01983 | Brevinin-2R | KLKNFAKGVAQSLLNKASCKLSGQC | Skin, Marsh frog, Europe | Activates the lysosomal-mitochondrial death pathway; Involves autophagy-like cell death | MTT-assay | MCF-7 | Breast adenocarcinoma | LD50 : 10 – 15 µg/ml |
| dbacp04130 | LK1 (Temporin-1CEa Analog peptide) | FVDLKKIANIINSIFKK | Synthetic construct | Cell membrane disintegration | MTT-assay | MCF-7 | Breast cancer | IC50 : 20.97 µM |
| dbacp04131 | LK1 (Temporin-1CEa Analog peptide) | FVDLKKIANIINSIFKK | Synthetic construct | Cell membrane disintegration | MTT-assay | Bcap-37 | Breast cancer | IC50 : 18.7 µM |
| dbacp04132 | LK1 (Temporin-1CEa Analog peptide) | FVDLKKIANIINSIFKK | Synthetic construct | Cell membrane disintegration | MTT-assay | MDA-MB-231 | Breast cancer | IC50 : 66.4µM |
| dbacp04133 | LK2(5) (Temporin-1CEa Analog peptide) | FKDLKKIANIINSIFKK | Synthetic construct | Cell membrane disintegration | MTT-assay | MCF-7 | Breast cancer | IC50 : 44.7 µM |
| dbacp04134 | LK2(5) (Temporin-1CEa Analog peptide) | FKDLKKIANIINSIFKK | Synthetic construct | Cell membrane disintegration | MTT-assay | Bcap-37 | Breast cancer | IC50 : 83.49 µM |
| dbacp04135 | LK2(5) (Temporin-1CEa Analog peptide) | FKDLKKIANIINSIFKK | Synthetic construct | Cell membrane disintegration | MTT-assay | MDA-MB-231 | Breast cancer | IC50 : 894.7 µM |
| dbacp04136 | LK2(6) (Temporin-1CEa Analog peptide) | FVKLKKIANIINSIFKK | Synthetic construct | Cell membrane disintegration | MTT-assay | MCF-7 | Breast cancer | IC50 : 15.54 µM |
| dbacp04137 | LK2(6) (Temporin-1CEa Analog peptide) | FVKLKKIANIINSIFKK | Synthetic construct | Cell membrane disintegration | MTT-assay | Bcap-37 | Breast cancer | IC50 : 18.9 µM |
| dbacp04138 | LK2(6) (Temporin-1CEa Analog peptide) | FVKLKKIANIINSIFKK | Synthetic construct | Cell membrane disintegration | MTT-assay | MDA-MB-231 | Breast cancer | IC50 : 85.41 µM |
| dbacp04139 | LK2(6)A(L) (Temporin-1CEa Analog peptide) | FVKLKKILNIINSIFKK | Synthetic construct | Cell membrane disintegration | MTT-assay | MCF-7 | Breast cancer | IC50 : 9.01 µM |
| dbacp04140 | LK2(6)A(L) (Temporin-1CEa Analog peptide) | FVKLKKILNIINSIFKK | Synthetic construct | Cell membrane disintegration | MTT-assay | Bcap-37 | Breast cancer | IC50 : 10.52 µM |
| dbacp04141 | LK2(6)A(L) (Temporin-1CEa Analog peptide) | FVKLKKILNIINSIFKK | Synthetic construct | Cell membrane disintegration | MTT-assay | MDA-MB-231 | Breast cancer | IC50 : 34.74 µM |
| dbacp04142 | LK2(6)AN(2L) (Temporin-1CEa Analog peptide) | FVKLKKILNIILSIFKK | Synthetic construct | Cell membrane disintegration | MTT-assay | MCF-7 | Breast cancer | IC50 : 11 µM |
| dbacp04143 | LK2(6)AN(2L) (Temporin-1CEa Analog peptide) | FVKLKKILNIILSIFKK | Synthetic construct | Cell membrane disintegration | MTT-assay | Bcap-37 | Breast cancer | IC50 : 9.39 µM |
| dbacp04144 | LK2(6)AN(2L) (Temporin-1CEa Analog peptide) | FVKLKKILNIILSIFKK | Synthetic construct | Cell membrane disintegration | MTT-assay | MDA-MB-231 | Breast cancer | IC50 : 41.55 µM |
| dbacp04145 | LK3 (Temporin-1CEa Analog peptide) | FKKLKKIANIINSIFKK | Synthetic construct | Cell membrane disintegration | MTT-assay | MCF-7 | Breast cancer | IC50 : 27.72 µM |
| dbacp04146 | LK3 (Temporin-1CEa Analog peptide) | FKKLKKIANIINSIFKK | Synthetic construct | Cell membrane disintegration | MTT-assay | Bcap-37 | Breast cancer | IC50 : 25.04 µM |
| dbacp04147 | LK3 (Temporin-1CEa Analog peptide) | FKKLKKIANIINSIFKK | Synthetic construct | Cell membrane disintegration | MTT-assay | MDA-MB-231 | Breast cancer | IC50 : 224.8 µM |